Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00791817 · ClinicalTrials.gov registry record · Phase 1

Study to Evaluate Potential Food Effects

A Phase 1 study of Healthy, sponsored by Procter and Gamble.

Completed
Registry status
Phase 1
Development phase
10
Enrollment target
1
Study location

NCT00791817 is a Phase 1 study of Healthy that has completed, run by Procter and Gamble. The registered enrollment target is 10 participants, below the 647-participant average among 1,090 other Healthy trials with a reported enrollment target (98% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00791817, a Phase 1 study of Healthy, has completed, sponsored by Procter and Gamble.

COMPLETED
Registry status
Phase 1
Development phase
10 participants
Enrollment target
1
Study location

Study Summary

Half the group will be given a high fat diet and the other half will fast. They will then be crossed over.

Conditions Studied

Interventions

  • DRUG PG-760564

Study Locations (1)

Florida

  • Stuart I Harris, MD, PhD - Miami

Trial Details

FieldValue
Enrollment Target 10 participants
Start Date 2005-08
Est. Completion 2006-01
Phase Phase 1

Sponsor

Procter and Gamble

70 total trials

What the Registry Record Tells You About NCT00791817

The ClinicalTrials.gov registry entry for NCT00791817 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 10 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 647-participant average among 1,090 other Healthy trials with a reported enrollment target (98% lower). The listed sponsor is Procter and Gamble, which has 70 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Healthy appearing as the primary indexed condition, and to 1 intervention - of which PG-760564 is the first listed.

NCT00791817 reports 1 study location spanning 1 distinct geographic area - top geographies include Florida.

Frequently Asked Questions

What is clinical trial NCT00791817 about?

NCT00791817 is a clinical study titled "Study to Evaluate Potential Food Effects". Half the group will be given a high fat diet and the other half will fast. They will then be crossed over.

What is the current status of trial NCT00791817?

This trial is currently completed. It is a Phase 1 study. The enrollment target is 10 participants. The study started on 2005-08. Estimated completion is 2006-01.

What conditions does trial NCT00791817 study?

This clinical trial studies the following conditions: Healthy.

What interventions are being tested in trial NCT00791817?

The interventions under investigation include: PG-760564 (DRUG).

Who is sponsoring clinical trial NCT00791817?

This trial is sponsored by Procter and Gamble, which has 70 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT00791817 being conducted?

This trial has 1 study location across Florida. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Healthy

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.